| Sesan Fatuade Ogunleye, MD | |
|
1301 3rd St, Suite 200, Wichita Falls, TX 76301-2245 | |
| (940) 767-5145 | |
| Not Available |
| Full Name | Sesan Fatuade Ogunleye |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 1301 3rd St, Wichita Falls, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982896742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25677 (Oklahoma) | Secondary |
| 207Q00000X | Family Medicine | 25677 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Haskell Memorial Hospital | Haskell, TX | Hospital |
| Christus Spohn Hospital Kleberg | Kingsville, TX | Hospital |
| Goodall Witcher Hospital | Clifton, TX | Hospital |
| Hereford Regional Medical Center | Hereford, TX | Hospital |
| Winkler County Memorial Hospital | Kermit, TX | Hospital |
| Entity Name | Texas Emergency Staffing Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811942949 PECOS PAC ID: 0345297610 Enrollment ID: O20050407001290 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Comanche County Medical Center Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346544616 PECOS PAC ID: 3678753357 Enrollment ID: O20110825000076 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | National Medical Professionals Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912120874 PECOS PAC ID: 3375859408 Enrollment ID: O20150903000965 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Hospital Care Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912945635 PECOS PAC ID: 9032131735 Enrollment ID: O20150915001950 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Hospital Care Consultants Of Corpus Christi |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275088452 PECOS PAC ID: 5092093153 Enrollment ID: O20161025002578 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Ess Of Port Lavaca Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922546936 PECOS PAC ID: 2769766005 Enrollment ID: O20170303001868 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Texas Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699288811 PECOS PAC ID: 0345508768 Enrollment ID: O20171212003035 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Guadalupe Emergency Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114425220 PECOS PAC ID: 0941561781 Enrollment ID: O20180219001747 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Shiloh Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982236170 PECOS PAC ID: 1759702228 Enrollment ID: O20200609002034 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Round Table Physicians Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023439114 PECOS PAC ID: 0547682460 Enrollment ID: O20200623002513 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Entity Name | Gulf Coast Emergency Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972286920 PECOS PAC ID: 6204280480 Enrollment ID: O20230921001356 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sesan Fatuade Ogunleye, MD 5601 Central Fwy Apt 3713, Wichita Falls, TX 76305-6723 Ph: (940) 851-0707 | Sesan Fatuade Ogunleye, MD 1301 3rd St, Suite 200, Wichita Falls, TX 76301-2245 Ph: (940) 767-5145 |
News Archive
Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.
Findings of a new multicenter study by Cotton et al. published today in the Journal of the American Medical Association comparing standard colonoscopy with CT colonography for the detection of colorectal cancer reveal that this technology, in the form used most often in the United States, while of significant interest, is not presently a viable option for routine colorectal cancer screening.
State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
› Verified 8 days ago
Dr. Ted Alexander, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-397-5400 Fax: 940-397-5482 | |
Brandon Christopher Ohman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1620 8th Street, Wichita Falls, TX 76301 Phone: 940-764-5400 Fax: 940-764-5454 | |
Salman S Aleem, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2612 Southwest Pkwy, #129, Wichita Falls, TX 76308 Phone: 940-767-5145 Fax: 940-767-3027 | |
Anas Albrejawi Alhomsi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1631 11th Street, Unit B, Wichita Falls, TX 76301 Phone: 940-263-3000 Fax: 940-263-3018 | |
Fezan Saleemi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 3rd St, Suite 200, Wichita Falls, TX 76301 Phone: 940-767-5145 Fax: 940-767-3027 | |
Siby Sam, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 3rd St Ste 200, Wichita Falls, TX 76301 Phone: 940-767-8334 | |
Micheal Allan Moisant, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4412 Kell West Blvd, Wichita Falls, TX 76309 Phone: 940-696-0011 Fax: 940-696-2248 |